Qurient partners with TB Alliance to develop new anti-tuberculosis agent by Editor | Feb 7, 2023 | LATEST NEWS, NGOs, Associations & Development Partners, Pharmaceuticals & Manufacturing, WORLD NEWS | 0 SOUTH KOREA — South Korean biotechnology company Qurient has entered a license agreement with TB... Read More